Please login to the form below

Not currently logged in
Email:
Password:

Paul Hudson

This page shows the latest Paul Hudson news and features for those working in and with pharma, biotech and healthcare.

Sanofi reports a profit in Q4 as Dupixent sales climb

Sanofi reports a profit in Q4 as Dupixent sales climb

of concept which reassure us about the priorities we chose,” said Paul Hudson, chief executive officer of Sanofi.

Latest news

More from news
Approximately 3 fully matching, plus 24 partially matching documents found.

Latest Intelligence

  • 20 for 2020 – Five pharma leaders to watch in 2020 20 for 2020 – Five pharma leaders to watch in 2020

    3. Paul Hudson – taking the helm at Sanofi. Another new chief executive with a lot on his plate in 2020 is Paul Hudson, who took over from Olivier Brandicourt at French ... Hudson takes over Sanofi at a transitional time for the French group, which

  • Integrating patient reported outcomes into clinical trials Integrating patient reported outcomes into clinical trials

    In explaining how his company designs its R&D portfolio, Johnson &Johnson chief scientific officer Paul Stoffels said “quality of life is the first metric” on a 2019 conference call with ... The quality-of-life data is probably one of the single

  • NHS regional footprints NHS regional footprints

    By Steve How, Paul Midgley and Oli Hudson, all part of Wilmington Healthcare’s Consulting Team, see www.wilmingtonhealthcare.com.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Covid-19 drives change in long-term conditions management

    Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore how patients are being empowered to manage their conditions at home. ... delivery. The time for digitally-supported pharma products is now. Ends. Paul Midgley is Director of NHS Insight and

  • Covid-19: how is it impacting on the NHS Long-term Plan?

    Oli Hudson and Paul Midgley, of Wilmington Healthcare, explain how coronavirus has expedited some parts of the plan but put others in jeopardy. ... Ends. Oli Hudson is Content Director and Paul Midgley is Director of NHS Insight, both at Wilmington

  • How will the Tories’ historic win shape the NHS?

    Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond. ... Ends. Paul Midgley is Director of NHS Insight and Oli Hudson is Content Director, both at Wilmington Healthcare.

  • 2019: A pivotal year for the NHS

    Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the key changes in the NHS in 2019. ... Ends. Paul Midgley is Director of NHS Insight and Oli Hudson is Content Director, both at Wilmington Healthcare.

  • Early diagnosis underpins NHS cancer strategy

    Paul Midgley, Oli Hudson and Sarah Shield, of Wilmington Healthcare, explore how the NHS is tackling cancer in line with the Long-term Plan. ... Ends. Paul Midgley is Director of NHS Insight; Sarah Shield is a Consultant and Oli Hudson is Content Director

More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical website. Support the...

Latest intelligence

Are you ready for the digital health revolution?
In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age....
#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...

Infographics